–Updated Results from the Bridge Trial: Long-Term Survival and Impact of Donor Availability–Clofarabine Salvage Therapy Prior to Allogeneic Hematopoietic Stem Cell … JM Middeke, R Herbst, SB Parmentier, G Bug, M Hänel, G Stuhler, ... Blood 124 (21), 1204, 2014 | 2 | 2014 |
‘Erythropoietin’Besser leben!–Länger leben? Symposium und Podiumsdiskussion. 28. April 2001, Curiohaus, Hamburg T Krauss, AH Nia, V Viereck, G Emons, A Hänel, R Herbst, A Morgner, ... Oncology Research and Treatment 24 (4), I-I, 2001 | | 2001 |
‘Neue Therapieperspektiven mit Irinotecan bei gastrointestinalen Tumoren’3rd International Conference ‘Perspectives in Colorectal Cancer’Dublin, 7.–9. Juni 2001 und … T Krauss, AH Nia, V Viereck, G Emons, A Hänel, R Herbst, A Morgner, ... Oncology Research and Treatment 24 (4), II-II, 2001 | | 2001 |
" Active in Aftercare"-First Evaluation Results of the Movement-Motivation Program for oncological Patients after completed Acute Therapy M Glausch, N Seidel, F Stoelzel, S Herrmann, K Prate, G Ehninger ONCOLOGY RESEARCH AND TREATMENT 40, 6-7, 2017 | | 2017 |
" Be smart against cancer"-interactive educational film on cancer prevention S Herrmann, N Seidel, F Stolzel, M Sommer, K Loewe, M Baumann, ... GESUNDHEITSWESEN 77, 2015 | | 2015 |
„Be smart against cancer “–interaktiver Lehrfilm zur Krebsvorbeugung S Herrmann, N Seidel, F Stölzel, M Sommer, K Löwe, M Baumann, ... Das Gesundheitswesen 77 (08/09), A3, 2015 | | 2015 |
“Human Development Index” Correlates with Rates and Influences Outcome of Hematopoietic Stem Cell Transplantation for Patients with Acute Leukemia. S Giebel, M Labopin, G Ehninger, DW Beelen, D Blaise, A Ganser, ... Blood 114 (22), 1193, 2009 | | 2009 |
„Start Speaking Stop Smoking “–ein Praxisbeispiel für Tabakprävention an Berufsbildenden Schulen S Herrmann, F Stölzel, N Seidel, M Baumann, G Ehninger Das Gesundheitswesen 76 (08/09), A71, 2014 | | 2014 |
(P72) Defining Predictive Factors for the Treatment of Relapsed Acute Myeloid Leukemia with Donor Cell Transfusion-Preliminary Data from a Retrospective Multi-Center Survey C Schmid, G Ehninger, J Finke, B Hertenstein, E Weissinger, R Arnold, ... ANNALS OF HEMATOLOGY 83, S32-S32, 2004 | | 2004 |
[131I]-Metaiodobenzylguanidine in the treatment of metastatic neuroblastoma: Clinical, pharmacological and dosimetric aspects T Klingebiel, J Treuner, G Ehninger, KD Keller, R Dopfer, U Feine, ... Cancer chemotherapy and pharmacology 25, 143-148, 1989 | 23 | 1989 |
1 Thrombozytopenien A Giagounidis, G Ehninger, E Hiller, A Matzdorff, MJ Rummel | | |
1.2 Allogeneic Stem Cell Transplantation after Reduced Conditioning in High-Risk Patients TK Held, J Schetelig, N Kroger, C Thiede, A Krusch, T Zabelina, M Dubiel, ... High Dose Therapy and Transplantation of Haemopoietic Stem Cells:(2001), 7, 2002 | | 2002 |
10 Prognose H Serve, U Brunnberg, C Thiede, G Ehninger, WE Berdel MMP-Verlag, 2008 | | 2008 |
10-year survival data after dose reduced conditioning with busulfan/fludarabine+/-ATG prior to allogeneic HCT K Sockel, M Bomhaeuser, N Kroeger, A Fauser, R Schwerdtfeger, ... ONKOLOGIE 33, 161-161, 2010 | | 2010 |
1010-lbp: Simulation of potential stem cell donor searches: Available matching donor is not always identified J Sauter, U Solloch, J Hofmann, J Pingel, AH Schmidt, G Ehninger Human Immunology 75 (6), 484, 2014 | | 2014 |
1013-lbp: identification of 2127 new HLA alleles in potential donors registered with DKMS donor centers in Germany, the United States and Poland CJ Hernandez-Frederick, AS Giani, N Cereb, R Silva-Gonzalez, J Pingel, ... Human Immunology 75 (6), 485, 2014 | | 2014 |
107 MONITORING OF THERAPEUTIC RESPONSE TO LENALIDOMIDE IN DEL (5Q) MDS USING A RAPID 5-PARAMETER FLOW CYTOMETRIC DEL (5Q)-SCORE U Oelschlaegel, B Mohr, K Sockel, C Thiede, G Ehninger, M Bornhäuser, ... Leukemia Research, S55, 2015 | | 2015 |
12 month molecular response< 1% BCR-ABL (IS) is associated with improved overall and progression-free survival in CML patients MC Mueller, A Hochhaus, M Lauseker, B Hanfstein, P Erben, ... ONKOLOGIE 34, 186-186, 2011 | | 2011 |
124-P: THE FUTURE HAS ARRIVED–ROUTINE HIGH THROUGHPUT HLA TYPING BY NGS V Lange, I Boehme, P Paul, JM Andreas, B Schoene, K Lang, DM Baier, ... Human Immunology 74, 135, 2013 | | 2013 |
160-P: neXtype: A SAFE CAR ON THE NGS ROLLER COASTER J Sauter, JA Hofmann, V Lange, I Böhme, K Lang, DM Baier, B Schöne, ... Human Immunology 74, 157, 2013 | | 2013 |